Invention Grant
- Patent Title: Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase
-
Application No.: US14853900Application Date: 2015-09-14
-
Publication No.: US09783528B2Publication Date: 2017-10-10
- Inventor: Scott L. Harbeson
- Applicant: Concert Pharmaceuticals, Inc.
- Applicant Address: US MA Lexington
- Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/40
- IPC: A61K31/40 ; C07D405/10 ; C07D403/06 ; C07B59/00
Abstract:
This invention relates to novel inhibitors of UDP-glucose: N-acyl-sphingosine glucosyltransferase and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering inhibitors of UDP-glucose: N-acyl-sphingosine glucosyltransferase.
Public/Granted literature
- US20160068519A1 INHIBITORS OF THE ENZYME UDP-GLUCOSE: N-ACYL-SPHINGOSINE GLUCOSYLTRANSFERASE Public/Granted day:2016-03-10
Information query
